Attis Global Pharma Private Limited
About Attis Global Pharma Private Limited
Data last updated:
Attis Global Pharma Private Limited is a private limited company based in Bengaluru, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 October 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51909KA2016PTC097451. Its GSTIN is 29AAOCA8868P2ZC (Karnataka). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gururajrao Gangavatikar and Jayarama Manjunath.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 101 Jahnavi Residency Yelahanka New Town A Sector, Bengaluru, Karnataka, India – 560064.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.51 Cr, a decline of 15% compared to the previous year. For the same year it recorded a net profit of ₹6.3 Lakh (net margin 1.4%) and EBITDA of ₹8.81 Lakh (EBITDA margin 2%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 16% over five years.
The company has 1 deal on record (1 secondary share transfer); the latest was in July 2017.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Attis Global Pharma Private Limited's registered office is in Bengaluru, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. 101 Jahnavi Residency Yelahanka New Town A Sector, Bengaluru, Karnataka, India – 560064
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Attis Global Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Attis Global Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Attis Global Pharma Private Limited, buy the company report.
Financials of Attis Global Pharma Private Limited
FY 2025 filings availableAttis Global Pharma Private Limited reported revenue of ₹4.51 Cr (down 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 15% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 16%. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.81 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.3 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Attis Global Pharma Private Limited, buy the company report.
Board of directors of Attis Global Pharma Private Limited
Attis Global Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gururajrao Gangavatikar Also directs: Suchirayu Health Care Solutions Limited | Director | 28 Oct 2016 | 10 Years 0 Months | Current |
| Jayarama Manjunath | Director | 10 Jul 2017 | 9 Years 3 Months | Current |
Auditor
Attis Global Pharma Private Limited is audited by GARGESH & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GARGESH & CO | FY 2017 | 007669S |
Shareholding
The shareholding of Attis Global Pharma Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Attis Global Pharma Private Limited, buy the company report.
Deals & funding
Attis Global Pharma Private Limited has 1 deal on record (1 secondary share transfer); the latest was in July 2017.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Attis Global Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Attis Global Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Attis Global Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAOCA8868P2ZC | Karnataka | Active | 01 Apr 2018 |
To see the full GST registrations and return filing status of Attis Global Pharma Private Limited, buy the company report.
Recent activity
Attis Global Pharma Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Jayarama Manjunath ceased to be Additional Director on 30 Dec 2017.
Frequently asked questions
Attis Global Pharma is an active private limited company based in Bengaluru, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 October 2016 (10+ years old) and is registered under CIN U51909KA2016PTC097451.
Attis Global Pharma has 2 current directors:
- Gururajrao Gangavatikar - Director
- Jayarama Manjunath - Director
The latest financial statements of Attis Global Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Attis Global Pharma is 29AAOCA8868P2ZC, registered in Karnataka. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Attis Global Pharma is U51909KA2016PTC097451. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Attis Global Pharma was incorporated on 28 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Bangalore.
Attis Global Pharma has 1 deal on record (1 secondary share transfer); the latest was in July 2017.
Jayarama Manjunath ceased to be Additional Director on 30 Dec 2017. Ashwani Kumar Srivastava ceased to be Director on 10 Jul 2017. Jayarama Manjunath was appointed as Director on 10 Jul 2017. Attis Global Pharma has 4 board changes on record in total.
The registered office of Attis Global Pharma is at Flat No. 101 Jahnavi Residency Yelahanka New Town A Sector, Bengaluru, Karnataka, India – 560064.
Attis Global Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
